Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Apoptosis À¯¹ß¿¡ ÀÇÇÑ ¥â-lapachone ÀÇ ÀÎüÆó¾Ï¼¼Æ÷ Áõ½Ä ¾ïÁ¦¿¡ °üÇÑ ¿¬±¸ Growth Inhibition of Human Lung Carcinoma Cells by ¥â-lapachone through Induction of Apoptosis

´ëÇѾϿ¹¹æÇÐȸÁö 2004³â 9±Ç 1È£ p.26 ~ 35
ÀÌÀçÈÆ, ¹Úö, ÃÖº´ÅÂ, ÀÌ¿øÈ£, ÃÖ¿µÇö,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÀçÈÆ ( Lee Jae-Hun ) 
µ¿ÀÇ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ »ýÈ­Çб³½Ç

¹Úö ( Park Cheol ) 
µ¿ÀÇ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ »ýÈ­Çб³½Ç
ÃÖº´Å ( Choi Byung-Tae ) 
µ¿ÀÇ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ÇغÎÇб³½Ç
ÀÌ¿øÈ£ ( Lee Won-Ho ) 
ºÎ»ê´ëÇб³ »ý¹°Çаú
ÃÖ¿µÇö ( Choi Yung-Hyun ) 
µ¿ÀÇ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ »ýÈ­Çб³½Ç

Abstract


The DNA topoismerase I inhibitor ¥â-lapachone, the product of a lapacho tree (Tabebuia avellanedae) from South America, activates a novel apoptotic response in a number of cell lines. In the present report, we investigated the effects of ¥â-lapachone on the growth of human lung in human non-small-cell-lung-cancer A549 cells. Upon treatment with ¥â-lapachone, a concentration-dependent inhibition of cell viability and cell proliferation was observed as measured by hemocytometer counts and MTT assay. The ¥â-lapachone- treated cells developed many of the hallmark features of apoptosis, including membrane shrinking, condensation of chromatin and DNA fragmentation. These apoptotic effects of ¥â-lapachone in A549 cells were associated with a marked induction of pro-apoptotic Bax expression, however the levels of anti-apoptotic Bcl-2 expression were decreased in a dose-dependent manner. Accordingly, elevated amount of cyclindependent kinase inhibitor p21 expression accompanied by up-regulation of tumor suppressor p53 was observed. By RT-PCR analyses, decrease in gene expression level of telomerase reverse transcriptase and telomeric repeat binding factor were also observed. Thus, these findings suggest that ¥â-lapachone may be a potential anti-cancer therapeutics for the control of human lung cancer cell model.

Å°¿öµå

¥â-lapachone ;Lung carcinoma; Apoptosis; Bax; Bcl-2

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸